If a doctor failed to diagnose your skin cancer or misread a biopsy in New York, a delay of just a few months can dramatically change your treatment options and long-term prognosis. Rheingold Giuffra Ruffo Plotkin & Hellman LLP helps individuals and families hold negligent medical providers accountable for diagnostic failures.
Driven by sun exposure and genetic factors, skin cancer remains a widespread health concern across the United States. A skin cancer misdiagnosis typically occurs in two directions:
Both situations can cause serious harm as a missed diagnosis delays life-saving care, while a false report subjects a patient to unnecessary surgery, scarring, and stress.
A delayed melanoma diagnosis is most likely to be catastrophic for patients, as early-stage melanoma is highly treatable, whereas advanced cases carry severe risks. If you believe your doctor misread a lesion or failed to order a biopsy, a New York cancer misdiagnosis lawyer can evaluate your clinical history to see if negligence occurred.
Melanoma claims require a distinct focus because time changes the nature of the disease.
When melanoma is caught while still confined to the outer layer of the skin, the long-term outlook is exceptionally strong. But as the tumor grows deeper, it reaches blood vessels and lymph nodes. Once it spreads, treatment becomes far more difficult.
In dermatology, the measurement that governs your prognosis is Breslow depth, the physical thickness of the tumor when it is finally cut out. Tumor depth increases over time. A delay of just a few months can push a patient across that line.
Data from the National Cancer Institute (NCI) SEER database underscores how quickly the stakes change:
Common conditions like basal cell carcinoma and squamous cell carcinoma are far more widespread and rarely fatal. Melanoma is different. Its ability to spread rapidly is why diagnostic delays in New York demand immediate legal review.
If you need help in pursuing a potential claim for a physician’s failure to diagnose cancer, contact the New York cancer diagnosis lawyers at Rheingold Giuffra Ruffo Plotkin & Hellman LLP today.
A failure to diagnose melanoma typically traces back to one of several common medical breakdowns:
A physician looks at a suspicious spot and makes a visual judgment that it is harmless. Instead of ordering a simple biopsy, they tell the patient not to worry, leaving a clear paper trail of a missed opportunity.
Sometimes the biopsy is performed, but a misread skin biopsy occurs in the lab. Pathologists must spot subtle cell changes under a microscope. Subtypes like nevoid or desmoplastic melanoma look deceptively normal, causing lab technicians to miss the malignancy entirely.
Ordinary moles, age spots, and atypical lesions share irregular borders and uneven colors with early melanoma, causing doctors to overlook real cancers.
A doctor notices a changing spot, notes it in the chart, and suggests a follow-up or a specialist referral. Then, communication breaks down. No one contacts the patient, the referral is never processed, and the changing spot goes unmonitored until it becomes advanced.
If you suspect a skin growth was overlooked or incorrectly evaluated, reviewing the standard clinical ABCDE criteria can help you assess your prior care:
Any lesion that continually changes, bleeds, itches, or refuses to heal demands immediate medical re-evaluation.
Patients should also know that they have the right to seek a second pathology opinion on an existing biopsy specimen. Medical laboratories are legally required to archive physical tissue blocks and glass slides for years. If you suspect an initial biopsy was misread, those exact physical slides can be retrieved and reviewed by an independent dermatopathologist to verify the original findings.
Establishing legal liability in a medical malpractice action requires demonstrating two core elements. First, you must show that the medical care fell below accepted professional standards, such as a failure to order a necessary biopsy or an error in interpreting pathology. Second, you must prove causation, meaning that earlier detection would have changed the ultimate medical outcome.
In melanoma litigation, the question of causation usually comes down to comparing the tumor depth and disease stage at the time of the missed opportunity versus the actual diagnosis.
Melanoma cases often depend on physical evidence that still exists years later. Medical laboratories are required to preserve original biopsy tissue blocks and glass slides. An independent dermatopathologist can re-examine these original archived slides to determine whether malignant cells were present and overlooked during the initial evaluation.
Timing is critical when pursuing legal recourse. Under New York CPLR 214-a, the general statute of limitations for medical malpractice actions is two years and six months from the date of the negligent act or omission.
However, for claims involving a failure to diagnose cancer or a malignant tumor, Lavern’s Law creates a discovery rule. Under this statute, the clock begins ticking when you discovered, or reasonably should have discovered, the misdiagnosis. All claims under Lavern’s Law remain subject to an absolute outer limit of seven years from the date the error occurred.
Successfully litigating misdiagnosis of skin cancer cases takes extensive medical knowledge, trial experience, and substantial firm resources. When a doctor fails to catch a malignancy early, your legal team must know how to uncover medical errors, challenge defense experts, and present complex clinical data to a jury.
Rheingold Giuffra Ruffo Plotkin & Hellman LLP has a team of New York medical malpractice attorneys that advocate for medical malpractice victims across NYC, including Manhattan, Brooklyn, Queens, and the Bronx, and throughout New York State, drawing on a 50-year practice history with over $2 billion recovered.
Building a strong case demands sophisticated medical proof. Led by experienced trial attorneys including Edward Ruffo and Thomas Giuffra, our firm retains top dermatopathologists to re-examine biopsy slides and prove stage progression. Our track record of significant case results, including a $2.5 million verdict against Richmond University Medical Center, reflects our technical approach to complex diagnostic litigation.
If you believe a melanoma or other skin cancer was missed, misdiagnosed, or diagnosed after an unreasonable delay, Rheingold Giuffra Ruffo Plotkin & Hellman LLP can review the circumstances of your case and help you get compensation for cancer misdiagnosis.
We offer free initial consultations, work on a contingency fee basis, and are conveniently located in Midtown Manhattan.
Call 212-684-1880 or submit your information through our contact page to discuss filing a cancer misdiagnosis lawsuit.
Melanoma is frequently missed when doctors rely on sight alone. Early melanomas can look harmless, and visual exams miss a significant percentage of them.
Yes. If a doctor evaluated a changing or atypical lesion and failed to perform a biopsy, allowing the cancer to advance, that decision can form the basis of a malpractice claim for failing to meet the standard of care.
You can legally request your original tissue slides from the facility that evaluated them. An independent dermatopathologist can re-examine those slides to verify whether the initial diagnosis was correct.
Under New York law (Lavern’s Law), you have two years and six months from the date you discovered, or reasonably should have discovered, the misdiagnosis, subject to an absolute seven-year limit from the date the error occurred.
If your melanoma or skin cancer was missed, misread, or diagnosed late, the answers are usually in your medical records and biopsy slides. In a free, confidential consultation, we will review what happened, explain which filing deadline applies under New York law, and help you understand your options.
We work on a contingency fee basis, and there is no obligation to file a claim. Call (212) 684-1880 or contact us online to get started.
